Search research articles
Contact Us
Filters
Showing results (101-110 of 117) with videos related to
Page
of 12
Sort By:
Human Antibodies
|
April 18, 2022
Assessment of specific human antibodies against SARS-CoV-2 receptor binding domain by rapid in-house ELISA
Nahla A Hussein, Esraa A A Ali, Amr E El-Hakim, et al.
Journal for Immunotherapy of Cancer
|
August 18, 2016
Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma
Asim Amin, David H Lawson, April K S Salama, et al.
Scientific Reports
|
September 7, 2018
Characterization of a lung epithelium specific E-cadherin knock-out model: Implications for obstructive lung pathology
S Post, I H Heijink, L Hesse, et al.
Tropical Animal Health and Production
|
April 18, 2024
Impact of different forms of selenium supplementation on growth and physiological performance of New Zealand white rabbits
Kout-Elkloub M El Moustafa, Hoda M El-Hosseiny, G F Shaheen, et al.
International Journal of Nephrology
|
November 25, 2021
Urinary Tract Infections in the First 6 Months after Renal Transplantation
Ziad Arabi, Khalefa Al Thiab, Abdulrahman Altheaby, et al.
Journal of Transplantation
|
July 26, 2021
The Impact of Timing of Stent Removal on the Incidence of UTI, Recurrence, Symptomatology, Resistance, and Hospitalization in Renal Transplant Recipients
Ziad Arabi, Khalefa Al Thiab, Abdulrahman Altheaby, et al.
Journal for Immunotherapy of Cancer
|
October 28, 2025
Genetic haplotypes in <i>VWA8, OSBPL6,</i> and <i>ADAMTS9-AS2</i> are associated with immune-related adverse effects in ICI-treated patients with cancer
Prithvi Raj, Jialiang Liu, Chengsong Zhu, et al.
Transplantation Proceedings
|
September 8, 2004
The new rHuEPO alpha (epotin) in the management of anemia of end-stage renal disease in patients on maintenance hemodialysis
E E Abbas, N Afioni, J Al Wakeel, et al.
Elife
|
July 5, 2022
Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an <i>N</i>-of-1 clinical trial
Montaser F Shaheen, Julie Y Tse, Ethan S Sokol, et al.
Journal for Immunotherapy of Cancer
|
June 12, 2021
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
Yousef Zakharia, Robert R McWilliams, Olivier Rixe, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 117) with videos related to
Sort By:
Page
of 12
Human Antibodies
|
April 18, 2022
Assessment of specific human antibodies against SARS-CoV-2 receptor binding domain by rapid in-house ELISA
Nahla A Hussein, Esraa A A Ali, Amr E El-Hakim, et al.
Journal for Immunotherapy of Cancer
|
August 18, 2016
Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma
Asim Amin, David H Lawson, April K S Salama, et al.
Scientific Reports
|
September 7, 2018
Characterization of a lung epithelium specific E-cadherin knock-out model: Implications for obstructive lung pathology
S Post, I H Heijink, L Hesse, et al.
Tropical Animal Health and Production
|
April 18, 2024
Impact of different forms of selenium supplementation on growth and physiological performance of New Zealand white rabbits
Kout-Elkloub M El Moustafa, Hoda M El-Hosseiny, G F Shaheen, et al.
International Journal of Nephrology
|
November 25, 2021
Urinary Tract Infections in the First 6 Months after Renal Transplantation
Ziad Arabi, Khalefa Al Thiab, Abdulrahman Altheaby, et al.
Journal of Transplantation
|
July 26, 2021
The Impact of Timing of Stent Removal on the Incidence of UTI, Recurrence, Symptomatology, Resistance, and Hospitalization in Renal Transplant Recipients
Ziad Arabi, Khalefa Al Thiab, Abdulrahman Altheaby, et al.
Journal for Immunotherapy of Cancer
|
October 28, 2025
Genetic haplotypes in <i>VWA8, OSBPL6,</i> and <i>ADAMTS9-AS2</i> are associated with immune-related adverse effects in ICI-treated patients with cancer
Prithvi Raj, Jialiang Liu, Chengsong Zhu, et al.
Transplantation Proceedings
|
September 8, 2004
The new rHuEPO alpha (epotin) in the management of anemia of end-stage renal disease in patients on maintenance hemodialysis
E E Abbas, N Afioni, J Al Wakeel, et al.
Elife
|
July 5, 2022
Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an <i>N</i>-of-1 clinical trial
Montaser F Shaheen, Julie Y Tse, Ethan S Sokol, et al.
Journal for Immunotherapy of Cancer
|
June 12, 2021
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
Yousef Zakharia, Robert R McWilliams, Olivier Rixe, et al.
Page
of 12